Research sponsored by Dendreon or Dendreon investigators has investigated - and continues to investigate - the clinical potential of PROVENGE® (sipuleucel-T) to extend the lives of men with early-stage to advanced prostate cancer. Dendreon-sponsored clinical and real-world PROVENGE studies, at various stages of completion, are listed at ClinicalTrials.gov
Find Clinical Trials
By searching, I confirm that my query is unsolicited.
ACTIVE, NOT RECRUITING